24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
OrbiMed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:14
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
OrbiMed
4 stories about OrbiMed
OrbiMed chooses against raising a third Israeli healthcare-dedicated fund
07.01.21
|
Meir Orbach
The investment firm raised a $307 million fund in 2016, but will not be founding another in a blow to the local ecosystem
Biological cancer treatment company Novellus raises $57 million
22.09.20
|
Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb
04.12.17
|
Meir Orbach
ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases